| Filed On | Filing |
|---|---|
| 17 Jun 2024 |
8-K/A: Financial Statements and Exhibits
We have audited the accompanying balance sheets of Trawsfynydd Therapeutics, Inc. (the “Company”) as of December 31, 2023 and 2022, and the related statements of operations, redeemable convertible preferred stock and stockholders’ defici... |
| 05 Aug 2021 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On August 2, 2021, the Compensation Committee of the Board of Directors (the “Compensation Committee”) of the Company approved (i) stock option awards to purchase the Company’s common stock (the “Options”) and (ii) restricted stock unit ... |
| 04 Mar 2021 |
8-K/A: Submission of Matters to a Vote of Security Holders; Other Events
On March 4, 2021, the Company held the Special Meeting. At the Special Meeting, the Company’s stockholders voted on the following proposal: |
Loading...